MOTS-c
Mitochondrial-derived Peptide (research chemical)
Preclinical evidence is genuinely interesting, and MOTS-c rises with exercise in humans, but no human administration trial of native MOTS-c exists — so therapeutic benefit is ungraded and safety is unknown.
How confident is BioSignal?
Our overall position, and how sure we are of it across each dimension — including where we are not sure at all.
Limited evidence
Preclinical evidence is genuinely interesting, and MOTS-c rises with exercise in humans, but no human administration trial of native MOTS-c exists — so therapeutic benefit is ungraded and safety is unknown.
Early or sparse human evidence; conclusions remain uncertain.
Human Evidence
No trial of native MOTS-c administration; human data are observational (MOTS-c rises with exercise).
Mechanistic Plausibility
AMPK activation, metabolic homeostasis, and muscle/healthspan effects in mice.
Research Activity
Active preclinical field; an analog reached early-phase trials then was discontinued.
Safety Profile
No human administration safety data for native MOTS-c; unregulated product.
Consensus
Not approved; no clinical guideline status.
Where the evidence stands today
How mature the science is, what kinds of evidence exist, and — the part nobody else prints — what is still missing.
4/9
steps proven in humans
Evidence-poor
5 steps not demonstrated: Human safety data · Small human outcome trials · Large human RCTs · Clinical outcomes · Guideline / regulatory support
Guideline / regulatory support
Not shownNot approved.
Clinical outcomes
Not shownNone.
Large human RCTs
Not shownNone.
Small human outcome trials
Not shownNone for native MOTS-c (an analog's early trials were discontinued).
Human safety data
Not shownNo administration of native MOTS-c to humans.
Human biomarker / pharmacology
ProvenObservational: endogenous MOTS-c rises with exercise.
Animal
ProvenMouse metabolic/physical-capacity effects.
Cell / in vitro
ProvenCell studies.
Mechanistic plausibility
ProvenAMPK activation; mitochondrial metabolism.
The bottom line
What we know, what we think, what we don't know — and what would change our mind.
Mouse efficacy; human correlation
In mice and cells, MOTS-c activates AMPK, improves metabolic homeostasis, reduces diet-induced obesity/insulin resistance, and improves physical capacity with aging; in humans, MOTS-c rises with exercise (observational).
Rises with exercise ≠ mimics exercise
It is a compelling research target for metabolism and aging — but 'rises with exercise' is not the same as 'taking it reproduces exercise.'
Everything about administration
Whether administering MOTS-c benefits humans at all, safe dose, long-term safety, and product quality are unknown.
Preclinical + a discontinued analog
Preclinical research continues; a synthetic MOTS-c analog (not native MOTS-c) entered early-phase trials that were discontinued.
What would change the picture
A human administration trial of native MOTS-c would allow the first graded efficacy claim.
The biggest myth
“Taking MOTS-c improves metabolism / mimics exercise in people.”
No human administration trial of native MOTS-c exists; effects are demonstrated in mice, not humans.
Ask BioSignal
Still have a question about mots-c?
Answers are retrieved from this record and the rest of the knowledge graph — never generated.
Why people take mots-c
Popularity is not evidence — but it is not stupid either. This explains the interest on its own terms.
People search MOTS-c for metabolic health, 'exercise-mimetic' effects, and longevity/mitochondrial support. Interest is not evidence: the efficacy data are in mice, the human data are observational (it rises with exercise), and there is no human administration trial — the proven way to raise your own MOTS-c is to exercise.
If you're here because…
Jump straight to the part of the evidence that answers your question.
Approval, safety and regulatory
What it is approved for, who should be careful, what remains unknown — and the limits of what this evidence can tell you.
Regulatory status
Not Approved
Availability
Unapproved research chemical
Sport (WADA)
Requires confirmation
Known safety profile
Unknown in humans for administered native MOTS-c (no trials); the analog's early-phase safety data pertain to a different molecule.
Common issues
- Not characterized in humans
Use caution if
- Everyone (unstudied)
- Cancer history
- Pregnancy
- Metabolic disease
Long-term unknowns
All long-term safety.
Limits of this evidence
Efficacy data are preclinical; human data are observational; no administration trial of native MOTS-c.
Full regulatory and sport detail
- Regulatory approval
- None.
- Approved indication
- None.
- Investigational
- Native MOTS-c not in trials; a synthetic analog (distinct molecule) reached early-phase trials that were discontinued — confirm details against a trial registry before publication.
- Research chemical
- Yes — sold as a research chemical.
- Compounding
- Not applicable.
- Sport (WADA)
- Status not clearly established — requires confirmation at publication.
- Publication note
- Re-confirm regulatory and anti-doping status against primary sources at publication.
Demand, separated from evidence
Every claim people make about this, counted against what the evidence actually showed.
BioSignal evaluated 4 popular claims about mots-c.
Here is where each one landed — including the claims of harm, where “not established” is reassuring rather than damning.
- Supported by evidence
- 1
- Not established
- 3
Popularity is not evidence. This is simply a count of every claim BioSignal evaluated on this page, sorted by what the evidence actually showed — the full reasoning behind each verdict is in the Evidence Review below.
Supported by evidence
- MOTS-c rises with exercise in humans.
Not established
- Taking MOTS-c improves metabolism / mimics exercise in people.
- MOTS-c is a proven longevity/exercise-mimetic therapy.
- MOTS-c is an available/approved therapy.
The evidence review
Every claim with the reasoning behind its verdict, the doses actually studied, where scientists agree and disagree, and the questions still open.
What people claim
Every popular claim, with BioSignal’s verdict and how confident we are in it. The verdicts are always visible; open any claim to read the evidence behind it.
MOTS-c rises with exercise in humans.SupportedLimited evidence
A small human study found exercise induces endogenous MOTS-c in muscle and blood (observational).
MOTS-c is a proven longevity/exercise-mimetic therapy.Not establishedLimited evidence
Preclinical only; no human efficacy data; an analog's early trials were discontinued.
MOTS-c is an available/approved therapy.Not establishedModerate confidence
Not approved; native MOTS-c has never been administered in a human trial; sold as a research chemical.
Doses used in human studies
What was actually given to participants in the research. These are descriptions of studies, not recommendations.
— (native MOTS-c)
- Intervention
- Administered MOTS-c
- Dose
- None
- Duration
- —
- Outcome
- —
- Notes
- No human administration trial of native MOTS-c exists.
Investigational (analog)
- Intervention
- MOTS-c analog (distinct molecule)
- Dose
- early-phase
- Duration
- —
- Outcome
- early-phase endpoints
- Notes
- Program discontinued; not native MOTS-c; details to confirm against trial registries.
Where scientists agree — and don’t
Agreed
- MOTS-c has real mitochondrial/metabolic biology in preclinical models and is exercise-induced in humans
Debated
- Whether exogenous administration would help humans
- Translation from mouse to human
Unknown
- All human administration efficacy, dose, and safety questions
What remains unknown
- Is there any human benefit from administering native MOTS-c?
- What is a safe human dose and the long-term safety?
- What is the product identity/purity in unregulated supply?
Questions people actually ask
Does MOTS-c work like exercise?
In mice, MOTS-c improves metabolism and physical capacity. In humans, it rises with exercise — but no one has tested giving native MOTS-c to people, so there is no human evidence that taking it reproduces exercise's benefits.
Can I take MOTS-c?
It is unapproved and experimental. Products sold online are unregulated research chemicals with no human administration trials and unknown safety.
Practical takeaways
- MOTS-c is a legitimately interesting research peptide — with strong mouse, not human, efficacy data.
- It rises with exercise in humans, but that does not mean taking it reproduces exercise.
- There are no human trials of administering native MOTS-c; benefit and safety are unknown.
- An analog reached early trials and was discontinued — not evidence of a working therapy.
- It is unapproved and experimental; the proven way to raise your own MOTS-c is to exercise.
How it works
The mechanism comes last on purpose. A compelling explanation of how something might work is the easiest part of the story to tell, and the part most likely to outlive the evidence for it.
How we found out
2015 — Lee (Cell Metab)
Discovery; MOTS-c improves metabolic homeostasis in mice.
2021 — Reynolds (Nat Commun)
Exercise induces MOTS-c in humans (observational); exogenous MOTS-c improves physical capacity in mice.
~2021–2023 — analog (distinct molecule)
Early-phase human trials discontinued; no approval.
References
Verified sources. BioSignal does not print a citation it has not checked.
- 01
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
Cell Metab 21(3):443-454 · 2015
- 02
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
Nat Commun 12(1):470 · 2021
Version history
1.0
Initial review-hardened record (Experimental; Insufficient/Caution). Review cadence: Annual.
Continue exploring
Three places this record leads next.